首页> 美国卫生研究院文献>Scientific Reports >C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
【2h】

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease

机译:脑脊液中淀粉样前体蛋白的C末端片段可作为阿尔茨海默氏病的潜在生物标记

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study assesses whether C-terminal fragments (CTF) of the amyloid precursor protein (APP) are present in cerebrospinal fluid (CSF) and their potential as biomarkers for Alzheimer’s disease (AD). Immunoprecipitation and simultaneous assay by Western blotting using multiplex fluorescence imaging with specific antibodies against particular domains served to characterize CTFs of APP in human CSF. We demonstrate that APP-CTFs are detectable in human CSF, being the most abundant a 25-kDa fragment, probably resulting from proteolytic processing by η-secretase. The level of the 25-kDa APP-CTF was evaluated in three independent CSF sample sets of patients and controls. The CSF level of this 25-kDa CTF is higher in subjects with autosomal dominant AD linked to PSEN1 mutations, in demented Down syndrome individuals and in sporadic AD subjects compared to age-matched controls. Our data suggest that APP-CTF could be a potential diagnostic biomarker for AD.
机译:这项研究评估了脑脊髓液(CSF)中是否存在淀粉样蛋白前体蛋白(APP)的C末端片段(CTF)及其作为阿尔茨海默氏病(AD)的生物标记物的潜力。使用针对特定结构域的特异性抗体的多重荧光成像,通过蛋白质印迹免疫沉淀和同时测定,来表征人CSF中APP的CTF。我们证明APP-CTFs在人类脑脊液中是可检测到的,是最丰富的25 kDa片段,可能是由η-分泌酶的蛋白水解过程引起的。在患者和对照的三个独立的CSF样本集中评估了25 kDa APP-CTF的水平。与年龄匹配的对照组相比,在具有与PSEN1突变相关的常染色体显性AD的受试者,痴呆的唐氏综合症患者和零星的AD受试者中,这种25 kDa CTF的CSF水平较高。我们的数据表明APP-CTF可能是AD的潜在诊断生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号